News
RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...
Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level. The ...
Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...
A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...
Pivot to U.S.-based Supply Chain for Critical Input Materials Completed - STONY BROOK, NY / ACCESS Newswire / April 21, 2025 ...
“With mRNA approaches, you don’t have to grow the virus to make a vaccine,” he says. “Instead, you can use available sequence information and draw similarities to other viruses.
When a tumor starts to grow in the body, small bits of its genetic material may break away and float off into the bloodstream. | Clinical And Molecular Dx ...
The German and EU patents at issue cover the engineering of mRNA molecules, including sequence modifications to increase stability and enhance protein expression, as well as mRNA formulations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results